Pediatria pre prax 2/2002
RSV infekce – současné možnosti léčby a imunoprofylaxe
RSV INFECTION – CURRENT THERAPY AND PREVENTION STRATEGIES The respiratory syncytial virus (RSV) is the major cause of bronchiolitis and pneumonia in children up to the age of 3. Premature infants, infants with chronic lung disease and children with congenital heart disease are at a high risk of RSV infection. This infection not only manifests as a serious acute phase but also there is a high incidence of late morbidity. RSV treatment modalities are mainly supportive and often controversial, immunoprophylaxis being the optimal approach. Key words: respiratory syncytial virus (RSV), prematurity, treatment, prophylaxis.